About Huada Gene
Huada Gene is a company based in Shenzhen (China) founded in 1999.. Huada Gene has raised $205 million across 2 funding rounds from investors including European Union, Everbright and Yunfeng Capital. Huada Gene has completed 1 acquisition, including Complete Genomics. Huada Gene offers products and services including Gene Sequencing and Clinical Detection Services.
- Headquarter Shenzhen, China
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Shenzhen Huada Gene Technology Co., Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$205 M (USD)
in 2 rounds
-
Latest Funding Round
-
Investors
European Union
& 5 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Huada Gene
Huada Gene offers a comprehensive portfolio of products and services, including Gene Sequencing and Clinical Detection Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Gene sequencing is performed for research and clinical purposes, including human and microbial genomes
Clinical detection services are offered for prenatal screening and tumor analysis to support health diagnostics
Funding Insights of Huada Gene
Huada Gene has successfully raised a total of $205M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(01 Jun 2012)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Grant - Huada Gene | Valuation |
investors |
|
| Jun, 2012 | Amount | Series C - Huada Gene | Valuation | China Everbright |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Huada Gene
Huada Gene has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Everbright and Yunfeng Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are managed by Yunfeng Capital in China.
|
Founded Year | Domain | Location | |
|
China-based startups are invested in by SBCVC across diverse sectors.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Huada Gene
Huada Gene has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Complete Genomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
DNA sequencing platform for human genome analysis is developed.
|
2006 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Huada Gene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Huada Gene Comparisons
Competitors of Huada Gene
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Huada Gene
When was Huada Gene founded?
Huada Gene was founded in 1999 and raised its 1st funding round 13 years after it was founded.
Where is Huada Gene located?
Huada Gene is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
Is Huada Gene a funded company?
Huada Gene is a funded company, having raised a total of $205M across 2 funding rounds to date. The company's 1st funding round was a Series C of $205M, raised on Jun 01, 2012.
What does Huada Gene do?
Huada Gene was founded in 1999 in Shenzhen, China. Operations are centered in the genomics sector, where genetic sequencing, analysis, and related biotechnology services are conducted. The company maintains a presence through its domain genomics.cn, supporting research and applications in molecular biology. Activities are primarily based in China, with limited details available on specific client engagements or expansions.
What products or services does Huada Gene offer?
Huada Gene offers Gene Sequencing and Clinical Detection Services.
How many acquisitions has Huada Gene made?
Huada Gene has made 1 acquisition, including Complete Genomics.
Who are Huada Gene's investors?
Huada Gene has 6 investors. Key investors include European Union, Everbright, Yunfeng Capital, Greenwoods Asset Management, and SBCVC.